AU3892593A - Composition for therapeutic or diagnostic use, process for its preparation and its use - Google Patents
Composition for therapeutic or diagnostic use, process for its preparation and its useInfo
- Publication number
- AU3892593A AU3892593A AU38925/93A AU3892593A AU3892593A AU 3892593 A AU3892593 A AU 3892593A AU 38925/93 A AU38925/93 A AU 38925/93A AU 3892593 A AU3892593 A AU 3892593A AU 3892593 A AU3892593 A AU 3892593A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- preparation
- composition
- diagnostic
- diagnostic use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6917—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a lipoprotein vesicle, e.g. HDL or LDL proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86525692A | 1992-04-08 | 1992-04-08 | |
| US865256 | 1992-04-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3892593A true AU3892593A (en) | 1993-11-18 |
Family
ID=25345059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU38925/93A Abandoned AU3892593A (en) | 1992-04-08 | 1993-04-07 | Composition for therapeutic or diagnostic use, process for its preparation and its use |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0634926A1 (en) |
| JP (1) | JPH07505408A (en) |
| KR (1) | KR950700726A (en) |
| AU (1) | AU3892593A (en) |
| CA (1) | CA2117749A1 (en) |
| WO (1) | WO1993020800A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09504797A (en) * | 1993-11-08 | 1997-05-13 | ペプチド デリバリー システムズ プロプリエタリイ リミテッド | Labeled diagnostic composition and method of use thereof |
| DE19500665A1 (en) * | 1995-01-12 | 1996-07-18 | Axel Prof Dr Haase | Process for the spatially resolving imaging of an area of a biological object with the help of electromagnetic rays using contrast media |
| GB2321455A (en) | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
| US5827533A (en) | 1997-02-06 | 1998-10-27 | Duke University | Liposomes containing active agents aggregated with lipid surfactants |
| AU2002365268B2 (en) | 2001-10-24 | 2008-02-28 | The Regents Of The University Of California | Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water |
| JP2005517904A (en) | 2002-02-12 | 2005-06-16 | ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア | A non-invasive method for measuring the rate of biosynthesis of biological molecules by label incorporation |
| JP4804753B2 (en) | 2002-07-30 | 2011-11-02 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Automated large-scale measurement of molecular flux rates of proteome or organeome using mass spectrometry |
| DE60324950D1 (en) * | 2002-09-13 | 2009-01-08 | Univ California | METHOD OF MEASURING THE SPEEDS OF CHOLESTER REVERSE TRANSPORT IN VIVO AS AN INDEX FOR ANTI-ARTHEROGENESIS |
| JP4611025B2 (en) | 2002-11-04 | 2011-01-12 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Deuterated glucose or fat tolerance test for high-throughput measurement of glucose or fatty acid metabolism in the body |
| US7262020B2 (en) | 2003-07-03 | 2007-08-28 | The Regents Of The University Of California | Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
| US20050202406A1 (en) | 2003-11-25 | 2005-09-15 | The Regents Of The University Of California | Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| TW200538738A (en) | 2004-02-20 | 2005-12-01 | Univ California | Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity |
| WO2013036885A1 (en) | 2011-09-08 | 2013-03-14 | The Regents Of The University Of California | Metabolic flux measurement, imaging and microscopy |
| CA2858368A1 (en) | 2011-12-07 | 2013-06-13 | Glaxosmithkline Llc | Methods for determining total body skeletal muscle mass |
| US9134319B2 (en) | 2013-03-15 | 2015-09-15 | The Regents Of The University Of California | Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo |
| KR102387248B1 (en) | 2021-07-06 | 2022-04-15 | (주)효림세울 | Equipment for manufacturing sirofil Composite Yarn and sirofil Composite Yarn and method for manufacturing sirofil Composite Yarn |
| KR102713065B1 (en) | 2022-04-11 | 2024-10-04 | (주)효림세울 | Equipment for manufacturing MOLTO JASPE yarn and method for manufacturing MOLTO JASPE yarn using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE456136B (en) * | 1985-06-17 | 1988-09-12 | Oncholab Ab | PROCEDURE FOR THE PREPARATION OF A LIPOPHILIC BIOLOGY ACTIVE SUBSTANCE BASED BEARING BASIS OF RECONSTITUTED LDL (Layer Density Lipoprotein) |
-
1993
- 1993-04-07 JP JP5518017A patent/JPH07505408A/en active Pending
- 1993-04-07 AU AU38925/93A patent/AU3892593A/en not_active Abandoned
- 1993-04-07 EP EP93907890A patent/EP0634926A1/en not_active Withdrawn
- 1993-04-07 WO PCT/FI1993/000149 patent/WO1993020800A1/en not_active Application Discontinuation
- 1993-04-07 CA CA002117749A patent/CA2117749A1/en not_active Abandoned
-
1994
- 1994-10-07 KR KR1019940703558A patent/KR950700726A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH07505408A (en) | 1995-06-15 |
| CA2117749A1 (en) | 1993-10-28 |
| KR950700726A (en) | 1995-02-20 |
| WO1993020800A1 (en) | 1993-10-28 |
| EP0634926A1 (en) | 1995-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU679663B2 (en) | Dermatological or pharmaceutical composition, preparation process and use | |
| AU4000293A (en) | Ophthalmologic cannula | |
| AU6373094A (en) | Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use | |
| SI0771788T1 (en) | Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them | |
| AU3072989A (en) | Skin treatment composition | |
| AU3892593A (en) | Composition for therapeutic or diagnostic use, process for its preparation and its use | |
| AU5229496A (en) | Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| AU2364597A (en) | Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| AU6209790A (en) | Pyridinyl-quinolone compounds, their preparation and use | |
| AU4556096A (en) | Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| AU5922694A (en) | 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use | |
| AU3455393A (en) | Preparation for skin use | |
| AU4926190A (en) | 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use | |
| AU5668286A (en) | Carbohydrate derivatives and compositions thereof for therapeutic or diagnostic use, and methods for their use | |
| AU4172693A (en) | Novel thienothiazine derivatives, process for their preparation and their use | |
| AU2068295A (en) | Skin treatment composition | |
| AU4994996A (en) | Composition for the treatment of diarrhea, its use and its preparation | |
| AU3155497A (en) | Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them | |
| AU2371397A (en) | Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them | |
| AU2353092A (en) | Substituted aminopropanes, processes for their preparation, and their use | |
| AU2752888A (en) | Use of known compounds, novel compounds and the use and processes for preparation thereof | |
| AU3900895A (en) | Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them | |
| AU5220893A (en) | Substituted N-hydroxycinnamamides, processes for their preparation, compositions containing them, and their use | |
| AU638082B2 (en) | Thiazolyl-5-carbonamide derivatives, the preparation thereof composition containing them and their use against microorganisms | |
| HUP9901126A3 (en) | Pharmaceutical composition for external use containing nimesulide and process for the preparation thereof |